Exact Mass: 426.2492
Exact Mass Matches: 426.2492
Found 104 metabolites which its exact mass value is equals to given mass value 426.2492,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Oxatomide
1-{3-[4-(diphenylmethyl)piperazin-1-yl]propyl}-2,3-dihydro-1H-1,3-benzodiazol-2-one
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents Oxatomide is a first-generation piperazine H1-antihistamine. D018926 - Anti-Allergic Agents Oxatomide is a potent and orally active dual H1-histamine receptor and P2X7 receptor antagonist with antihistamine and anti-allergic activity. Oxatomide almost completely blocks the ATP-induced current in human P2X7 receptors (IC50 of 0.95 μM). Oxatomide inhibits ATP-induced Ca2+ influx with an IC50 value of 0.43 μM and also inhibits serotonin[1][2].
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-4-hydroxy-3-methoxy-alpha-(1-methylethyl)-
Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-4-hydroxy-3-methoxy-alpha-(1-methylethyl)-
(4S,7R)-7-[(1E,3E,5E,7E)-8-[(2S,5R,6S)-5,6-dihydro-5-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione|wortmannilactone F
(4S,7R)-7-[(1E,3E,5E,7E)-8-[(2S,5R,6S)-5,6-dihydro-5-hydroxy-3,5,6-trimethyl-2H-pyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione|wortmannilactone F
(5Z,8Z,11Z,13E,17Z)-2-eicosa-15(S)-hydroxy-5,8,11,13,17-pentaenoylphloroglucinol
(5Z,8Z,11Z,13E,17Z)-2-eicosa-15(S)-hydroxy-5,8,11,13,17-pentaenoylphloroglucinol
7alpha,21-dihydroxy-3-oxo-24,25,26,27-tetranorapotirucall-1,14,20(22)-trien-21,23-olide
7alpha,21-dihydroxy-3-oxo-24,25,26,27-tetranorapotirucall-1,14,20(22)-trien-21,23-olide
16beta-acetyloxy-14-hydroxy-bufa-5,20,22-trienolide
16beta-acetyloxy-14-hydroxy-bufa-5,20,22-trienolide
(5beta,9alpha,10alpha)-7-O-(3alpha-methoxy-8(12)-drimen-11-yl)-scopoletin|driportlandin
(5beta,9alpha,10alpha)-7-O-(3alpha-methoxy-8(12)-drimen-11-yl)-scopoletin|driportlandin
Ile Pro Pro Thr
(2S,3R)-2-{[(2S)-1-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid
Ile Pro Thr Pro
(2S)-1-[(2S,3R)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid
Ile Thr Pro Pro
(2S)-1-{[(2S)-1-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid
Leu Pro Pro Thr
(2S,3R)-2-{[(2S)-1-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid
Leu Pro Thr Pro
(2S)-1-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid
Leu Thr Pro Pro
(2S)-1-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid
Pro Ile Pro Thr
(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}butanoic acid
Pro Ile Thr Pro
(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanoyl]pyrrolidine-2-carboxylic acid
Pro Leu Pro Thr
(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanoyl]pyrrolidin-2-yl]formamido}butanoic acid
Pro Leu Thr Pro
(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]butanoyl]pyrrolidine-2-carboxylic acid
Pro Pro Ile Thr
(2S,3R)-3-hydroxy-2-[(2S,3S)-3-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]butanoic acid
Pro Pro Leu Thr
(2S,3R)-3-hydroxy-2-[(2S)-4-methyl-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}pentanamido]butanoic acid
Pro Pro Thr Ile
(2S,3S)-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]-3-methylpentanoic acid
Pro Pro Thr Leu
(2S)-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-{[(2S)-pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}butanamido]-4-methylpentanoic acid
Pro Thr Ile Pro
(2S)-1-[(2S,3S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid
Pro Thr Leu Pro
(2S)-1-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid
Pro Thr Pro Ile
(2S,3S)-2-{[(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid
Pro Thr Pro Leu
(2S)-2-{[(2S)-1-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid
Thr Ile Pro Pro
(2S)-1-{[(2S)-1-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid
Thr Leu Pro Pro
(2S)-1-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidine-2-carboxylic acid
Thr Pro Ile Pro
(2S)-1-[(2S,3S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid
Thr Pro Leu Pro
(2S)-1-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid
Thr Pro Pro Ile
(2S,3S)-2-{[(2S)-1-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid
Thr Pro Pro Leu
(2S)-2-{[(2S)-1-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]carbonyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid
2-eicosa-15S-hydroxy-5Z,8Z,11Z,13E,17Z-pentaenoylphloroglucinol
15S-Hydroxy-1-(2,4,6-trihydroxyphenyl)-5Z,8Z,11Z,13E,17Z-eicosapentaen-1-one
oxatomide
oxatomide
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AE - Piperazine derivatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D018926 - Anti-Allergic Agents Oxatomide is a potent and orally active dual H1-histamine receptor and P2X7 receptor antagonist with antihistamine and anti-allergic activity. Oxatomide almost completely blocks the ATP-induced current in human P2X7 receptors (IC50 of 0.95 μM). Oxatomide inhibits ATP-induced Ca2+ influx with an IC50 value of 0.43 μM and also inhibits serotonin[1][2].
N-[3-(diethylamino)propyl]-4-[(2-methyl-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)hydrazo]-4-oxobutanamide
N-[3-(diethylamino)propyl]-4-[(2-methyl-[1,2,4]triazolo[1,5-c]quinazolin-5-yl)hydrazo]-4-oxobutanamide
(3aS,5S,9aS)-2-[(2-methylphenyl)methyl]-5-(1-methyl-3-phenyl-4-pyrazolyl)-3a,4,5,7,8,9-hexahydro-3H-pyrrolo[3,4-h]pyrrolizin-1-one
(3aS,5S,9aS)-2-[(2-methylphenyl)methyl]-5-(1-methyl-3-phenyl-4-pyrazolyl)-3a,4,5,7,8,9-hexahydro-3H-pyrrolo[3,4-h]pyrrolizin-1-one
1-(4-Azidobenzyl)-4-[2-(diphenylmethoxy)ethyl]piperidine
1-(4-Azidobenzyl)-4-[2-(diphenylmethoxy)ethyl]piperidine
SB269652
SB269652
SB269652 is the first drug-like allosteric modulator of the dopamine D2 receptor (D2R); a new chemical probe that can differentiate D2R monomers from dimers or oligomers depending on the observed pharmacology. IC50 value: 0.2/0.5 nM [1] Target: D3 receptor antagonist SB269,652 potently (low nanomolar range) abolished specific binding of [(3)H]nemanopride and [(3)H]spiperone to Chinese hamster ovary-transfected D(3) receptors when radioligands were used at 0.2 and 0.5 nM, respectively. However, even at high concentrations (5 μM), SB269,652 only submaximally inhibited the specific binding of these radioligands when they were employed at 10-fold higher concentrations. By analogy, although SB269,652 potently blocked D(3) receptor-mediated activation of Gα(i3) and phosphorylation of extracellular-signal-regulated kinase (ERK)1/2, when concentrations of dopamine were increased by 10-fold, from 1 μM to 10 μM, SB269,652 only submaximally inhibited dopamine-induced stimulation of Gα(i3) [1].
(1s,2r,5s,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate
(1s,2r,5s,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate
(7r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6s)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(7r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6s)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
7-[8-(3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
7-[8-(3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
5,5'-diisopropyl-3,3',8,8'-tetramethyl-[2,2'-binaphthalene]-1,1'-diol
5,5'-diisopropyl-3,3',8,8'-tetramethyl-[2,2'-binaphthalene]-1,1'-diol
(1s,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione
(1s,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione
7-[8-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
7-[8-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
methyl (1r,2s,6s,15s,16r)-9-(ethylamino)-11-(2-hydroxyethyl)-2,15-dimethyl-18-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-9,11,13-triene-12-carboxylate
methyl (1r,2s,6s,15s,16r)-9-(ethylamino)-11-(2-hydroxyethyl)-2,15-dimethyl-18-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-9,11,13-triene-12-carboxylate
(6ar)-3,6a-dimethyl-9-[(2s)-2-methyldodecanoyl]furo[2,3-h]isochromene-6,8-dione
(6ar)-3,6a-dimethyl-9-[(2s)-2-methyldodecanoyl]furo[2,3-h]isochromene-6,8-dione
2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol
2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol
(2r,3s,4s,5r,6r)-3,4,5-trimethoxy-2-(methoxymethyl)-6-{[(2s,3s,4s)-1,3,4,5-tetramethoxypentan-2-yl]oxy}oxane
(2r,3s,4s,5r,6r)-3,4,5-trimethoxy-2-(methoxymethyl)-6-{[(2s,3s,4s)-1,3,4,5-tetramethoxypentan-2-yl]oxy}oxane
(5z,8z,11z,13e,15s,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one
(5z,8z,11z,13e,15s,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one
(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5s,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
6,8-dimethoxy-7-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]chromen-2-one
6,8-dimethoxy-7-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]chromen-2-one
7-{6-formyl-2-hydroxy-3-methyl-2-[2-methyl-3-(sec-butyl)oxiran-2-yl]-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl}hepta-2,4,6-trienoic acid
7-{6-formyl-2-hydroxy-3-methyl-2-[2-methyl-3-(sec-butyl)oxiran-2-yl]-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl}hepta-2,4,6-trienoic acid
15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-3-ene-5,13-dione
15-(furan-3-yl)-10-hydroxy-2,7,7,11,16-pentamethyl-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-3-ene-5,13-dione
(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate
(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate
(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(7r)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(1r,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione
(1r,1's,2's,5's,9's,10'r,13'r,14's)-5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione
(13z,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol
(13z,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol
(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3r,3ar,4s,6ar)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3r,3ar,4s,6ar)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
2-{[(1s,2s,5s,6s,7r,10r,11s)-5-hydroxy-5,7,11-trimethyl-12-oxo-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-6-yl]methyl}cyclohexa-2,5-diene-1,4-dione
2-{[(1s,2s,5s,6s,7r,10r,11s)-5-hydroxy-5,7,11-trimethyl-12-oxo-13-oxatetracyclo[9.3.3.0¹,¹⁰.0²,⁷]heptadecan-6-yl]methyl}cyclohexa-2,5-diene-1,4-dione
3-[(1s,2s,3s)-2,3-dimethyl-2-{[(2-oxochromen-7-yl)oxy]methyl}-6-(propan-2-ylidene)cyclohexyl]propyl acetate
3-[(1s,2s,3s)-2,3-dimethyl-2-{[(2-oxochromen-7-yl)oxy]methyl}-6-(propan-2-ylidene)cyclohexyl]propyl acetate
(1s,13r,14s,17s,19s)-10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate
(1s,13r,14s,17s,19s)-10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate
(13e,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol
(13e,21r)-2-oxatricyclo[20.2.2.1³,⁷]heptacosa-1(24),3,5,7(27),13,22,25-heptaene-5,21,24,25-tetrol
3,4,5-trimethoxy-2-(methoxymethyl)-6-[(1,3,4,5-tetramethoxypentan-2-yl)oxy]oxane
3,4,5-trimethoxy-2-(methoxymethyl)-6-[(1,3,4,5-tetramethoxypentan-2-yl)oxy]oxane
10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate
10-hydroxy-7-imino-13,14,18,18-tetramethyl-2-oxa-6-azapentacyclo[11.8.0.0¹,¹⁷.0³,¹¹.0⁴,⁸]henicosa-3(11),4(8),9-trien-19-yl acetate
(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3s,3as,4r,6as)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(4s,6r)-7-[(1e,3e,5e)-6-[(2s,3s,3as,4r,6as)-3-hydroxy-2,3,5,6a-tetramethyl-2h,3ah,4h-cyclopenta[b]furan-4-yl]hexa-1,3,5-trien-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
3,6a-dimethyl-9-(2-methyldodecanoyl)furo[2,3-h]isochromene-6,8-dione
3,6a-dimethyl-9-(2-methyldodecanoyl)furo[2,3-h]isochromene-6,8-dione
(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6r)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(4s,6r)-7-[(1e,3e,5e,7e)-8-[(2s,3r,6r)-3-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one
15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one
6,8-dimethoxy-7-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}chromen-2-one
6,8-dimethoxy-7-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}chromen-2-one
5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione
5',10',14'-trimethyl-6',16'-dioxaspiro[cyclohexane-1,7'-pentacyclo[12.3.3.0¹,¹³.0²,¹⁰.0⁵,⁹]icosan]-3-ene-2,5,15'-trione
(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate
(1s,2r,5r,6s,7s,9r)-5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate
(2e,4e,6e)-7-[(1s,2r,4ar,8ar)-2-[(2s,3r)-3-[(2r)-butan-2-yl]-2-methyloxiran-2-yl]-6-formyl-2-hydroxy-3-methyl-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoic acid
(2e,4e,6e)-7-[(1s,2r,4ar,8ar)-2-[(2s,3r)-3-[(2r)-butan-2-yl]-2-methyloxiran-2-yl]-6-formyl-2-hydroxy-3-methyl-4a,5,8,8a-tetrahydro-1h-naphthalen-1-yl]hepta-2,4,6-trienoic acid
(5z,8z,11z,13e,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one
(5z,8z,11z,13e,17z)-15-hydroxy-1-(2,4,6-trihydroxyphenyl)icosa-5,8,11,13,17-pentaen-1-one
5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate
5-(acetyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenylprop-2-enoate
(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
(1s,4s,6r,7s)-7-[(1e,3e,5e,7e)-8-[(2s,5r,6s)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]nona-1,3,5,7-tetraen-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione
